Bloomberg Podcasts
@bloombergpodcasts·503K subscribers·32.4K videos
Fresnillo AstraZeneca Climbs, Argenx Surges | Stock Movers
Posted
August 17, 2026
Views
89
August 17, 2026
89
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
3:26Now PlayingToday's biggest winners and losers in the stock market.
On this episode of Stock Movers:
- Fresnillo shares rise alongside other British mining companies as copper advances towards a record, with a key spread in London widening to extreme levels in a sign of competition for prompt supply.
- AstraZeneca shares rise as much as 1.4% after the pharmaceutical giant said it is stopping a clinical trial of the experimental drug volrustomig, which didn’t look set to help fight lung cancer better than existing therapies.
- Argenx shares jump as much as 10%, the most in more than a year, after the company announced positive late-stage trial results for its experimental myositis treatment.
See omnystudio.com/listener () for privacy information.
Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies making news on Wall Street.
Check out more episodes of Stock Movers
Follow Bloomberg Podcasts on Twitter
Visit our other YouTube channels:
Bloomberg Television
Bloomberg Originals
For coverage on news, markets and more
#Stocks #Markets #Finance #Investing #Podcast #Bloomberg
Fresnillo AstraZeneca Climbs, Argenx Surges
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.
